Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001374 |
Azacitidine |
Azacitidine results in decreased methylation of CLDN6 promoter | decreases methylation | 18661270
|
D001374 |
Azacitidine |
Azacitidine results in increased expression of CLDN6 mRNA | increases expression | 18661270
|
D001374 |
Azacitidine |
[trichostatin A co-treated with Azacitidine] results in decreased methylation of CLDN6 promoter | affects cotreatment|decreases methylation | 18661270
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN6 mRNA] | decreases expression|decreases reaction | 18661270
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide results in decreased methylation of CLDN6 promoter | decreases methylation | 18661270
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide results in increased expression of CLDN6 mRNA | increases expression | 18661270
|
D005031 |
Ethylenethiourea |
Ethylenethiourea results in decreased expression of CLDN6 mRNA | decreases expression | 18801409
|
D006861 |
Hydrogen Peroxide |
Dimethyl Sulfoxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN6 mRNA] | decreases expression|decreases reaction | 18661270
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide affects the expression of CLDN6 mRNA | affects expression | 18661270
|
C494474 |
perchlorate |
perchlorate results in decreased expression of CLDN6 mRNA | decreases expression | 18801409
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CLDN6 mRNA | increases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CLDN6 mRNA | increases expression | 16236135
|
C012589 |
trichostatin A |
[trichostatin A co-treated with Azacitidine] results in decreased methylation of CLDN6 promoter | affects cotreatment|decreases methylation | 18661270
|
C012589 |
trichostatin A |
trichostatin A results in decreased methylation of CLDN6 promoter | decreases methylation | 18661270
|
C012589 |
trichostatin A |
trichostatin A results in increased expression of CLDN6 mRNA | increases expression | 18661270
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of CLDN6 mRNA | increases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 15322242 11752688 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Ethylenethiourea |
3.93 | 7955072 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.78 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.19 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.64 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.63 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.63 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.96 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.88 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.48 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.90 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.34 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.65 | 16936243 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.20 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.88 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.48 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.02 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.02 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.96 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.72 | 19934284 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.50 | 9664655 16925845 9224671 10589399 14991402 17551590 9142499 9125849 9211117 8800419 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.58 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.58 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
13.03 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
13.03 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.96 | 19294695 |
MESH:D018159 |
Endolymphatic Hydrops |
|
Dimethyl Sulfoxide |
6.88 | 20641076 |
MESH:D016889 |
Endometrial Neoplasms |
|
Ethylenethiourea |
8.50 | 7955072 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
8.50 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.34 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.34 | 9664655 16938888 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.50 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.50 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.84 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.84 | 18801729 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.53 | 18801409 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.32 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Dimethyl Sulfoxide |
5.35 | 20641076 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.48 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.86 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.86 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.15 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.37 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.83 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.95 | 12200463 12878042 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.02 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.63 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.63 | 15992940 17551590 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.48 | 16518626 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
6.96 | 19148494 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.96 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
10.49 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
10.49 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
6.53 | 18720364 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.53 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
6.53 | 18206229 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.41 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.28 | 16766008 17339181 17368321 19035177 16140955 19642359 17712046 16823087 15748426 17294898 17217047 16788101 12679006 17649720 9834237 17107899 17506722 19225113 16331271 19029980 16891316 16935935 19075265 17301526 17361223 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.45 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethyl Sulfoxide |
3.76 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.76 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.76 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Ethylenethiourea |
5.25 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
5.25 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.22 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
2.66 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.66 | 11884234 19555203 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.85 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.71 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
3.71 | 16505122 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.68 | 16940565 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.40 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
8.37 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
8.37 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
8.07 | 18720364 19805378 17596541 17611569 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
8.07 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.49 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.32 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.32 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.18 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.34 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
5.34 | 19331143 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.78 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
5.78 | 19294695 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
4.34 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11896295 11118676 11222880 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
5.51 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
3.84 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
3.84 | 18798265 19789329 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.82 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.08 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.32 | 16116481 16283617 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
9.99 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.99 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.99 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Ethylenethiourea |
8.32 | 11940454 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
8.32 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.98 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.34 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.87 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.93 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.29 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.15 | 16287080 |